Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center Randomized Clinical Trial Correlating the Effects of 24 Months of Exemestane or Letrozole on Surrogate Markers of Response With Aromatase Polymorphism

NCT00228956 is registered in ClinicalTrials.gov with National Institute of General Medical Sciences (NIGMS) as lead sponsor.

NCT NCT00228956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00228956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center Randomized Clinical Trial Correlating the Effects of 24 Months of Exemestane or Letrozole on Surrogate Markers of Response With Aromatase Polymorphism
Lead sponsor
National Institute of General Medical Sciences (NIGMS)
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2005
Completion date
February 28, 2009
Enrollment
500 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer